Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

glucagon-like peptide 1 (7-37)

Known as: GLP-I (7-37), insulinotropin, GLP-1 (7-37) 
 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Glucagon-Like Peptide 1Peptide Fragments
Incretins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial
AbstractAims/hypothesisHigh-energy breakfast and reduced-energy dinner (Bdiet) significantly reduces postprandial glycaemia in… Expand
  • table 1
  • table 2
  • figure 2
  • table 3
2010
2010
Intra-Islet PACAP Protects Pancreatic β-Cells Against Glucotoxicity and Lipotoxicity
Pituitary adenylate cyclase-activating polypeptide (PACAP), a potent insulinotropin, is localized in pancreatic islets… Expand
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2007
Highly Cited
2007
Amino acids are more important insulinotropins than glucose in a teleost fish, barfin flounder (Verasper moseri).
  • T. Andoh
  • General and comparative endocrinology
  • 2007
    • Corpus ID: 27448715
The insulinotropic effects of eighteen L-amino acids, two D-amino acids, and glucose were investigated to evaluate the priority… Expand
2002
2002
Effects of glucagon-like peptide-1(7-36) amide on neurohypophysial and cardiovascular functions under hypo- or normotensive hypovolaemia in the rat.
To date, glucagon-like peptide 1(7-36) amide (tGLP-1) has been found to affect the neurohypophysial and cardiovascular functions… Expand
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
2001
2001
Degradation and glycemic effects of His7-glucitol glucagon-like peptide-1(7–36)amide in obese diabetic ob/ob mice
Glucagon-like peptide-1(7-36)amide (tGLP-1) has attracted considerable potential as a possible therapeutic agent for type 2… Expand
2000
2000
N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo.
Glucagon-like peptide-1(7-36)amide (tGLP-1) is inactivated by dipeptidyl peptidase (DPP) IV by removal of the NH(2)-terminal… Expand
1999
1999
Insulinotropin PACAP potentiates insulin-stimulated glucose uptake in 3T3 L1 cells☆
Pituitary adenylate cyclase-activating polypeptide (PACAP) is localized in pancreatic nerve fibers and islets and potently… Expand
Highly Cited
1996
Highly Cited
1996
The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein.
To examine whether incretin hormones, truncated glucagon-like peptide-1 (tGLP-1) and glucose-dependent insulinotropic polypeptide… Expand
Highly Cited
1990
Highly Cited
1990
Characterization of high‐affinity receptors for truncated glucagon‐like peptide‐1 in rat gastric glands
The truncated form of glucagon‐like peptide‐1 (TGLP‐1, or proglucagon 78–108), secreted by the mammalian intestine, has potent… Expand
Highly Cited
1987
Highly Cited
1987
Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
Insulin secretion is controlled by a complex set of factors that include not only glucose but amino acids, catecholamines, and… Expand
  • figure 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE